A hopeful therapy for Niemann-Pick C diseases - The Lancet
Por um escritor misterioso
Descrição
Improved systemic AAV gene therapy with a neurotrophic capsid in
PDF) Identification of Niemann–Pick C1 (NPC1) disease biomarkers
Therapeutic intervention for Niemann–Pick type C disease must
A hopeful therapy for Niemann-Pick C diseases,The Lancet - X-MOL
Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological
Hope For Marian Foundation Fighting Niemann Pick Type C
PDF) A therapy with miglustat, 2-hydroxypropyl-ß-cyclodextrin and
Improved systemic AAV gene therapy with a neurotrophic capsid in
Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological
Full article: New therapies in the management of Niemann-Pick type
Inhibition of Histone Deacetylases 1, 2, and 3 Enhances Clearance
Catatonia in neurodevelopmental disorders: assessing catatonic
Miglustat for treatment of Niemann-Pick C disease: a randomised
de
por adulto (o preço varia de acordo com o tamanho do grupo)
